Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04225676
Title Study of Efficacy and Safety of Reinfusion of Tisagenlecleucel in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia (ALL)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

acute lymphoblastic leukemia

Therapies

Tisagenlecleucel

Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
Childrens Hospital Los Angeles Divisionof Hematology/Oncology Los Angeles California 90027 United States Details
Ann and Robert H Lurie Childrens Hospital of Chicago Chicago Illinois 60611 United States Details
Children s Mercy Hospital Kansas City Missouri 64108 United States Details
UT Southwestern Medical Center Dallas Texas 75235 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field